CD30 is a crucial marker in distinguishing ALK-positive ALCL, typically showing diffuse CD30 expression from ALK-positive LBCL, which is CD30-negative or only weakly positive [88]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.